Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals Inc.
WKN: A2ACMZ / Symbol: IONS / Name: Ionis Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
47,75 €
0,87 %
Ionis Pharmaceuticals (IONS) had its price target lowered by Royal Bank Of Canada from $100.00 to $85.00. They now have an "outperform" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by HC Wainwright from $125.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by Wells Fargo & Company from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by JPMorgan Chase & Co. from $72.00 to $76.00. They now have an "overweight" rating on the stock.
Ratings data for IONS provided by MarketBeat
Neueste Beiträge
Canaccord_Genuity_Gr in Neurocrine Bioscience diskutieren